Voloridge Investment Management’s Boston Scientific BSX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $217M | Buy |
+2,018,678
| New | +$217M | 0.8% | 14 |
|
2023
Q3 | – | Sell |
-490,291
| Closed | -$26.5M | – | 1389 |
|
2023
Q2 | $26.5M | Buy |
+490,291
| New | +$26.5M | 0.13% | 228 |
|
2022
Q2 | – | Sell |
-265,976
| Closed | -$11.8M | – | 1434 |
|
2022
Q1 | $11.8M | Buy |
265,976
+141,687
| +114% | +$6.28M | 0.07% | 372 |
|
2021
Q4 | $5.28M | Buy |
+124,289
| New | +$5.28M | 0.03% | 705 |
|
2021
Q1 | – | Sell |
-1,369,526
| Closed | -$49.2M | – | 1405 |
|
2020
Q4 | $49.2M | Buy |
+1,369,526
| New | +$49.2M | 0.41% | 41 |
|
2020
Q3 | – | Sell |
-106,035
| Closed | -$3.72M | – | 1258 |
|
2020
Q2 | $3.72M | Buy |
106,035
+36,616
| +53% | +$1.29M | 0.04% | 431 |
|
2020
Q1 | $2.27M | Sell |
69,419
-367,048
| -84% | -$12M | 0.07% | 320 |
|
2019
Q4 | $19.7M | Buy |
+436,467
| New | +$19.7M | 0.38% | 45 |
|
2019
Q2 | – | Sell |
-115,384
| Closed | -$4.43M | – | 774 |
|
2019
Q1 | $4.43M | Sell |
115,384
-109,255
| -49% | -$4.19M | 0.13% | 157 |
|
2018
Q4 | $7.94M | Buy |
+224,639
| New | +$7.94M | 0.36% | 78 |
|
2017
Q2 | – | Sell |
-1,489,358
| Closed | -$37M | – | 425 |
|
2017
Q1 | $37M | Buy |
1,489,358
+1,273,836
| +591% | +$31.7M | 0.9% | 16 |
|
2016
Q4 | $4.66M | Sell |
215,522
-1,791,597
| -89% | -$38.8M | 0.1% | 262 |
|
2016
Q3 | $47.8M | Buy |
2,007,119
+1,213,310
| +153% | +$28.9M | 1.04% | 9 |
|
2016
Q2 | $18.6M | Buy |
+793,809
| New | +$18.6M | 0.53% | 57 |
|
2015
Q3 | – | Sell |
-747,784
| Closed | -$13.2M | – | 286 |
|
2015
Q2 | $13.2M | Buy |
+747,784
| New | +$13.2M | 0.67% | 35 |
|